Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,521–7,540 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

PHO-TID-CHOL 50MG/ DEOXYCHOLIC 42 MG/ML INJ, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0953-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

ONDANSETRON 2 MG/ML INJECTION SOLUTION (PFV), 2 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0158-02

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MOXIFLOXACIN 0.5% OPHTH SOLUTION SYRINGE, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0973-81

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0138-89

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MOLYBDENUM 0.025MG/ML INJECTION SOLUTION, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0964-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MIC B12 W/B6 (LIPOSTAT PLUS) 25/50/50/1/.175 MG/ML, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0978-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

METHYLCOBALAMIN (PFV) 10 MG/ML INJECTABLE, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0902-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

METHYLCOBALAMIN 10MG/ML INJECTABLE SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0130-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0952-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MAGNESIUM CHLORIDE HEXAHYDRATE (PFV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0951-50

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MAGNESIUM CHLORIDE HEXAHYDRATE (MDV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0977-50

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

LIDOCAINE HCL 2% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0172-20

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXOCOBALAMIN 1000 MCG/ML (MDV), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0926-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXOCOBALAMIN 1000 MCG/ML (PFV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0949-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROGEN PEROXIDE 3% INJECTABLE PFV, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0907-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

GLUTATHIONE 200MG/ML (MDV) INJECTION SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0906-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

FOLIC ACID 10MG/ML INJECTION SOLUTION (MDV), 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0921-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0207-89

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.